Boston-based PE-backed joint venture Katalyst launches

Boston-based Katalyst LLC, a joint venture between Gordon Brooks and Housatonic Partners, has launched. Katalyst will focus on acquiring companies that are mostly in the healthcare and insurance business services sector. The company is planning on investing up to $40 million to support this mission. Also, Brooks will handle chairman and CEO duties for Katalyst.



KATALYST LLC (KATALYST), a special purpose acquisition company, today announced its launch. The new company, headquartered in Boston, Massachusetts, will focus on acquiring companies primarily in the healthcare and insurance business services industries as part of a strategy to build a market transforming business services company through the use of advanced technology such as the Internet of Things and Cloud Computing. The company plans to invest up to $40 million of equity capital to support the strategy. Gordon Brooks will serve as the Chairman and Chief Executive Officer of KATALYST.

KATALYST has partnered with Housatonic Partners, a leading private equity firm with over $1 billion in capital under management. “I am thrilled to have the opportunity to work with Housatonic Partners to build an industry leading transformational technology enabled business services company,” said Mr. Brooks. “We believe that the intersection of technology and brick and mortar can provide an opportunity to change how market segments operate, sell, buy and compete. Our primary focus is on the insurance and healthcare markets focusing on technology enabled business services with a special interest in transformation through the Internet of Things and Cloud Computing. We are actively seeking acquisitions and believe we are in a unique position to evaluate and pursue select assets in these highly fragmented and rapidly growing markets.”

Gordon has more than 30 years of science and technology experience with companies like CSC, ADP, Oracle, Cambridge Technology Partners, Breakaway Solutions, Symphony Teleca and Quercegen Pharmaceuticals and Return on Intelligence. Gordon has founded and helped launch six new companies in the last nineteen years resulting in two IPO’s with a combined market cap of over $8 billion, one spinoff and sale, seven entity sales and seventeen acquisitions. “We are very excited to partner with Gordon to build a leading technology enabled business services company,” said Housatonic Managing Director Mark Hilderbrand. “Gordon has an exceptional track record over his career, with diverse experience in multiple market segments and a history of driving organic and M&A growth. Gordon’s industry expertise, strategic vision and operational abilities make him an ideal partner as Housatonic commits to building a transformational business services company.”

KATALYST was formed in September 2015 as a partnership between Gordon Brooks and Housatonic Partners. KATALYST’s mission is to build a transformative company in the healthcare and insurance industries by acquiring outstanding brick and mortar and early stage technology businesses to transform how the selected market segment operates, buys, sells and competes. For more information about KATALYST please contact us at (857) 453-6605, or visit us on the web at

About Housatonic Partners
Housatonic Partners is a private equity investment firm founded in 1994 with $1 billion in capital under management. The firm focuses on growth buyouts and recapitalizations of profitable service businesses with highly recurring revenue. In partnership with exceptional management, Housatonic has led investments in more than 60 small to mid-sized companies.